Unlocking the Next Frontier in Sickle Cell Therapy: Researchers Identify the "BACH2-NRF2 Axis" as a New Regulator of Fetal Hemoglobin
In a significant leap forward for hematology and genetic medicine, a research team led by Vijay G. Sankaran, MD, PhD,...
